METHODS AND COMPOSITION FOR A BINDING MOLECULE TARGETING CANCER CELLS EXPRESSING SSX2 PEPTIDE 41-49 IN HLA-A*0201 CONTEXT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20220185909A1
SERIAL NO

17552862

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are Synovial Sarcoma X breakpoint 2 binding molecules and methods for their use in the detection and treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GEORGE WASHINGTON UNIVERSITY1922 F STREET NW WASHINGTON DC 20052

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOLLARD, Catherine Bethesda, US 9 2
HELD, Gerhard Homburg, DE 2 5
PFREUNDSCHUH, Michael Homburg, DE 36 238
RASKIN, Scott Silver Spring, US 1 0
STURM, Christine Homburg, DE 1 0
VAN, PELT Stacey Houston, US 1 0
YVON, Eric Bethesda, US 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation